The Combination of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma—Is Not the Answer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference44 articles.
1. Cancer statistics, 2007.;Jemal;CA Cancer J Clin,2007
2. Renal-cell carcinoma.;Motzer;N Engl J Med,1996
3. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.;Rosenberg;N Engl J Med,1987
4. Subcutaneous recombinant interleukin-2 (rIL-2) in out-patients with metastatic renal cell carcinoma. Results of a multicenter SCAPP1 trial.;Tourani;Ann Oncol,1996
5. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.;Fyfe;J Clin Oncol,1995
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The prospects for combination therapy with capecitabine in the rapidly evolving treatment landscape of renal cell carcinoma;Expert Opinion on Investigational Drugs;2018-01-24
2. Improvements in Clinical Trials Information Will Improve the Reproductive Health and Fertility of Cancer Patients;Journal of Adolescent and Young Adult Oncology;2017-06
3. Cytotoxic chemotherapy in the treatment of advanced renal cell carcinoma in the era of targeted therapy;Critical Reviews in Oncology/Hematology;2015-12
4. A Comprehensive Overview of Targeted Therapy in Metastatic Renal Cell Carcinoma;Current Cancer Drug Targets;2012-08-01
5. Chemotherapy-Induced Peripheral Neuropathy;Chemotherapy-Induced Neuropathic Pain;2012-07-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3